Create Alert
Watchlist

Neuland Laboratories

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹18,275Cr
ROE13.30%
P/E Ratio(TTM)70.26
EPS(TTM)202.74
P/B Ratio11.99
Dividend Yield0.08%
Industry P/E35.91
Book Value1187.77
Debt to Equity0.10
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Neuland Labs

Neuland Laboratories Limited is an India-based company, which is engaged in manufacturing and selling of bulk drugs. The Company caters to both domestic and international markets. It manufactures active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs. The Company provide solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company operates through a single segment, manufacture of active pharmaceutical ingredients and allied services. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services.;
Parent OrganisationNeuland Laboratories Limited
Managing DirectorMr. Davuluri Rao
NSE SymbolNEULANDLAB

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Retail And Others
34.07%
Promoters
32.68%
Foreign Institutions
21.69%
Mutual Funds
7.66%
Other Domestic Institutions
3.91%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
81.55
Jubilant Pharmova
NA
(0.00%)
23.44
Acutaas Chemicals
NA
(0.00%)
62.06
Aarti Drugs
NA
(0.00%)
28.58